The US medical research agency plans to offer funding over five years through a newly launched consortium, expected to include 30 sites across the country.
Invitrogen plans to cement its place as one of the world's largest
suppliers of analysis tools and reagents for the life science and
pharmaceutical industries by acquiring Applied Biosystems (ABI).